References
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al.: GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide2010: IARC Cancer Base No. 10 [http://globocan.iarc.fr/]. Lyon, France: International Agency for Research on Cancer. Available from: http://globocan.iarc.fr, accessed on 03/11/2012.
- Beaulieu N, Bloom D, Bloom R, and Stein R. Breakaway: The Global Burden of Cancer—Challenges and Opportunities. London, UK: The Economist Intelligence Unit, 2009.
- Lalitha K, Suman G, Pruthvish S, Mathew A, and Murthy NS: Estimation of time trends of incidence of prostate cancer—an Indian scenario. Asian Pacific J Cancer Prev 13(12), 6245–6250, 2012.
- Jain S, Saxena S, and Kumar A: Epidemiology of prostate cancer in India. Meta Gene 2, 596–605, 2014.
- National Cancer Registry Programme (NCRP). Time trends in Cancer Incidence rates 1982–2005, Indian Council of Medical Research, Bangalore, India, 2009.
- Clinton SK and Giovannucci E: Diet, nutrition and prostate cancer. Annu Rev Nutr 18, 413–440, 1998.
- Abdulla M and Gruber P: Role of diet modification in cancer prevention. Biofactors 12, 45–51, 2000.
- Gordaliza M: Natural products as leads to anticancer drugs. Clin Transl Oncol 9, 67–776, 2007.
- Bommareddy A, Eggleston W, Prelewicz S, Antal A, Witczak Z, et al.: Chemoprevention of prostate cancer by major dietary phytochemicals. Anticancer Res 33, 4163–4174, 2013.
- Kumar N and Chornokur G: Molecular targeted therapies using botanicals for prostate cancer chemoprevention. Transl Med S2, 005, 2012.
- Yu H, Zhang ZI, Chen J, Pei A, Hua F, et al.: Carvacrol, a food-additive, provides neuroprotection on focal cerebral ischemia/reperfusion injury in mice. PLoS One 7, e33584, 2012.
- Martins RRL, Neves MG, Sivestre AJD, Silva A, and Cavaleiro JAS: Oxidation of aromatic monoterpene with hydrogen peroxide catalyzed by Mn(III) porphyrin complexes. J Molcatal A: Chem 137, 41–47, 1999.
- Aligiannis N, Kalpoutzakis E, Mitaku S, and Chinou IB: Composition and antimicrobial activity of essential oils of two Origanum species. J Agric Food Chem 49, 4168–4170, 2001.
- Arcila Lozano CC: Oregano: properties, composition and biological activity. Arch Latinoam Nut 54, 100–111, 2004.
- Sokmen M, Serkedjieva J, Daferera D, Gulluce M, Polissiou M, et al.: In vitro antioxidant, antimicrobial and antiviral activities of the essential oil and various extract from herbal parts and callus cultures of Origanum acutidens. J agric Food Chem 52, 3309–3312, 2004.
- Kisk G and Roller S: Carvacrol and p-cymene inactivate Escherichia coli O157:H7 in apple juice. BMC Microbiol 5, 36, 2005.
- Lampronti I, Saab AM, and Gambari R: Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division. Int J Oncol 29, 989–995, 2006.
- Horvathova E, Turcanniova V, and Slamenova D: Comparative study of DNA-damaging and DNA-protective effects of selected components of essential plant oils in human leukemic cells K562. Neoplasma 54, 478–483, 2007.
- Baser KHC: Biological and pharmacological activities of carvacrol and carvacrol bearing essential oils. Curr Pharm Des 14, 3106–3119, 2008.
- Gany ZSA and Mahdi MF: Cytotoxic assay of Nigella sativa leaf callus extract (thymol) on hep-3 cell line using ELISA assay. Iraqi J Pharma Sci 17, 63–67, 2008.
- Giweli A, Dz'amic' AM, Sokovic' M, Ristic' MS, and Marin PD: Antimicrobial and antioxidant activities of essential oils of Satureja thymbra growing wild in Libya. Molecules 17, 4836–4850, 2012.
- Koparal AT and Zeytinoglu M: Effects of carvacrol on a human non-small cell lung cancer (NSCLC) cell line, A549. Cytotechnology 43, 149–154, 2003.
- Karkabounas S, Kostoula OK, Daskalou T, Veltsistas P, Karamouzis M, et al.: Anticarcinogenic and antiplatelet effects of carvacrol. Exp Oncol 28, 121–125, 2006.
- Arunasree KM: Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. Phytomedicine 17, 581–588, 2010.
- Mehdi SJ, Ahmad A, Irshad M, Manzoor N, and Rizvi MMA: Cytotoxic effect of Carvacrol on human cervical cancer cells. Biol Med 3(2), 307–312, 2011.
- Yin QH, Yan FX, Zu XY, Wu YH, Wu XP, et al.: Anti-proliferative and pro-apoptotic effect of carvacrol on human hepatocellular carcinoma cell line HepG-2. Cytotechnology 64, 43–51, 2012.
- Patel B, Shah VR, and Bavadekar SA: Anti-proliferative effects of carvacrol on human prostate cancer cell line, LNCaP. FASEB J 26, 1037.5, 2012.
- Ahmed, Shousha WG, El-Mezayen HA, Ismaiel NN, and Mahmoud NS: In vivo antitumor potential of carvacrol against hepatocellular carcinoma in rat model. World J Pharm Pharm Sci 2, 2367–2396, 2013.
- Yang CB, Pei WJ, Zhao J, Yuan-yuan Cheng YY, et al.: Bornyl-caffeate induces apoptosis in human breast cancer MCF-7 cells via the ROS- and JNK-mediated pathways. Acta Pharmacol Sin 35(1), 113–123, 2013.
- Prasad R and Katiyar SK: Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules. PLoS One 7(9), e46404, 2012.
- Das S, Dey KK, Dey G, Pal I, Majumder A, et al.: Antineoplastic and apoptotic potential of traditional medicines thymoquinone and diosgenin in squamous cell carcinoma. PLoS One 7(10), e46641, 2012.
- Ahamad MS, Siddiqui S, Jafri A, Ahmad S, Afzal M, et al.: Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ROS generation and cell cycle arrest. PLoS One 9(10), e110003, 2014.
- Xiong Y, Ye T, Wang M, Xia Y, Wang N, et al.: A novel cinnamide YLT26 induces breast cancer cells apoptosis via ROS mitochondrial apoptotic pathway in vitro and inhibits lung metastasis in vivo. Cell Physiol Biochem 34, 1863–1876, 2014.
- Qi H, Siu SO, Chen Y, Han Y, Chu IK, et al.: Senkyunolides reduce hydrogen peroxide-induced oxidative damage in human liver HepG2 cells via induction of heme oxygenase-1. Chem Biol Interact 183, 380–389, 2010.
- Qi H, Chen B, Le XC, and Rong J: Concomitant induction of heme Oxygenase-1 attenuates the cytotoxicity of arsenic species from lumbricus extract in human liver HepG2 cells. Chem Biodivers 9, 739–754, 2012.
- Mishra T, Arya RK, Meena S, Joshi P, Pal M, et al.: Isolation, characterization and anticancer potential of cytotoxic triterpenes from Betula utilis bark. PLoS One 11(7), e0159430, 2016.
- Sarkar S, Mazumdar A, Dash R, Sarkar D, Fisher PB, et al.: ZD6474, adual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERKand AKT/PI3-K and induces apoptosis in breast cancer cells. Cancer Biol Ther 9(8), 592–603, 2010.
- Krishna Moorthy H and Venugopal P: Strategies for prostate cancer prevention—review of the literature. Indian J Urol 24, 295–302, 2008.
- Donaldson MS: Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr J 3, 19, 2004.
- Shukla S and Gupta S: Dietary agents in the chemoprevention of prostate cancer. Nutr Cancer 53(1), 18–32, 2005.
- Melchini A, Traka MH, Catania S, Miceli N, Taviano MF, et al.: Antiproliferative activity of the dietary isothiocyanate erucin, a bioactive compound from cruciferous vegetables, on human prostate cancer cells. Nutr Cancer 65(1), 132–138, 2013.
- Lall RK, Syed DN, Adhami VM, Khan MI, and Mukhtar H: Dietary polyphenols in prevention and treatment of prostate cancer. Int J Mol Sci 16, 3350–3376, 2015.
- Teiten MH, Gaascht F, Dicato M, and Diederich M: Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions. Biochem Pharmacol 86(9), 1239–1247, 2013. doi: 10.1016/j.bcp.2013.08.007
- Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, et al.: Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 12, 1463–1467, 2005.
- Wong RSY: Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res 30, 87, 2011.
- Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, et al.: Appearance of phosphatidylserine on apoptotic cells requires calcium mediated nonspecific flip-flop and is enhanced by loss of the amino phospholipid translocase. J Biol Chem 272, 26159–26165, 1997.
- Cohen GM: Caspases: the executioners of apoptosis. Biochem J 326(1), 1–16, 1997.
- Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, et al.: A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272, 17907–17911, 1997.
- Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, et al.: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391, 43–50, 1998.
- Nagata S: Apoptotic DNA fragmentation. Exp Cell Res 256, 12–18, 2000.
- Cordero CM, González AJL, Montaño JMC, Morón EB, and Lázaro ML: Pro-oxidant natural products as anticancer agents. Curr Drug Targets 13, 1006–1028, 2012.
- Fruehauf JP and Meyskens FL: Reactive oxygen species: a breath of life or death? Clin Cancer Res 13, 789–794, 2007.
- Trachootham D, Alexandre J, and Huang P: Targeting cancer cells by ROS mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Disc 8, 579–591, 2009.
- Scaduto Jr RC and Grotyohann LW: Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J 76, 469–477, 1999.
- Balaban R: Modeling mitochondrial function. Am J Physiol Cell Physiol 291, C1107–C1113, 2006.
- Emaus RK, Grunwald R, and Lemasters JJ: Rhodamine-123 as a probe of transmembrane potential in isolated rat-liver mitochondria-spectral and metabolic properties. Biochim Biophys Acta 850, 436–448, 1986.
- Polla BS, Kantengwa S, Francois D, Salvioli S, Franceschit C, et al.: Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA 93, 6458–6463, 1996.
- Duan J, Yin Y, Wei G, Cui J, Zhang E, et al.: Chikusetsu saponin IVa confers cardioprotection via SIRT1/ERK1/2and Homer1a pathway. Sci Rep 5, 18123, 2015.